iANTHUS CAPITAL HOLDINGS (ITHUF) EBIT Margin (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly EBIT Margin came in at 6.84% in Q1 2026, down 156.0% year-on-year from 12.21% in Q1 2025, and up 36.37% quarter-over-quarter from 10.74% in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) EBIT Margin (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed EBIT Margin across 7 years of filings, most recently posting 6.84% for Q1 2026.
- EBIT Margin for Q1 2026 came in at 6.84%, down 156.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 11.26% (down 982.0% YoY), and the FY2025 annual result was 10.71%, down 753.0% from the prior year.
- EBIT Margin came in at 6.84% for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from 10.74% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 25.95% in Q4 2023 to a low of 116.92% in Q4 2022.
- The 5-year median for EBIT Margin is 12.0% (2025), against an average of 22.09%.
- Across the five-year window, EBIT Margin plunged 10619 bps in 2022 and surged 14287 bps in 2023, its largest moves.
- iANTHUS CAPITAL HOLDINGS's EBIT Margin stood at 116.92% in 2022, then surged by 122 bps to 25.95% in 2023, then slumped by 90 bps to 2.64% in 2024, then slumped by 507 bps to 10.74% in 2025, then surged by 36 bps to 6.84% in 2026.
- The last three EBIT Margin figures came in at 6.84% (Q1 2026), 10.74% (Q4 2025), and 12.0% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -122.23% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -12.88% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | -6.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.84% |
| Dec 31, 2025 | -10.74% |
| Sep 30, 2025 | -12.00% |
| Jun 30, 2025 | -15.26% |
| Mar 31, 2025 | -5.27% |
| Dec 31, 2024 | 2.64% |
| Sep 30, 2024 | -3.12% |
| Jun 30, 2024 | -0.52% |
| Mar 31, 2024 | -11.94% |
| Dec 31, 2023 | 25.95% |
| Sep 30, 2023 | -19.89% |
| Jun 30, 2023 | -15.05% |
| Mar 31, 2023 | -25.38% |
| Dec 31, 2022 | -116.92% |
| Sep 30, 2022 | -34.86% |
| Jun 30, 2022 | -104.47% |
| Mar 31, 2022 | -21.91% |
| Dec 31, 2021 | -38.41% |
| Sep 30, 2021 | -9.71% |
| Jun 30, 2021 | 1.72% |